SCHEMBL5569669

SCHEMBL5569669

CCCOc1ccc(C(O)CN)cc1Cl

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CSNK2A1 P68400 2/20 0.57
NFKB1 P19838 1/20 0.47
GLA P06280 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
BLM P54132 3/20 0.46
PMP22 Q01453 1/20 0.46
MAPT P10636 3/20 0.42
MEN1 O00255 3/20 0.42
KMT2A Q03164 3/20 0.42
HPGD P15428 2/20 0.42
APEX1 P27695 2/20 0.42
RECQL P46063 2/20 0.42
TDP1 Q9NUW8 2/20 0.42
KDM4E B2RXH2 2/20 0.42
LMNA P02545 1/20 0.42
ADRB2 P07550 1/20 0.42
ADRB1 P08588 1/20 0.42
ADRA2A P08913 1/20 0.42
ADORA3 P0DMS8 1/20 0.42
ADRB3 P13945 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7146924 0.81 NFKB1 (0.64) NFKB1SMN1; SMN2BLMPMP22MAPT
SCHEMBL2065519 0.81 NFKB1 (0.64) NFKB1SMN1; SMN2BLMPMP22MAPT
SCHEMBL27898486 0.81 NFKB1 (0.64) NFKB1SMN1; SMN2BLMPMP22MAPT
Hydrochloric Acid SCHEMBL2065125 0.80 BLM (0.65) NFKB1SMN1; SMN2BLMPMP22MAPT
Hydrochloric Acid SCHEMBL6760975 0.80 BLM (0.65) NFKB1SMN1; SMN2BLMPMP22MAPT
SCHEMBL12356908 0.80 CSNK2A1 (0.57) CSNK2A1GLASMN1; SMN2MAPTMEN1
SCHEMBL5569665 0.79 CSNK2A1 (0.58) CSNK2A1NFKB1BLMPMP22MAPT
SCHEMBL16959180 0.77 CSNK2A1 (0.54) CSNK2A1GLASMN1; SMN2MAPTMEN1
SCHEMBL7914446 0.75 NFKB1 (0.60) NFKB1BLMPMP22ADRA2AADRA1A
SCHEMBL25101010 0.74 TAAR1 (0.50) NFKB1SMN1; SMN2MAPTMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070219192-A1 Certain chemical entities, compositions, and methods CYTOKINETICS, INCORPORATED 2007-09-20 US claimed
US-20070219192-A1 Certain chemical entities, compositions, and methods CYTOKINETICS, INCORPORATED 2007-09-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070219192-A1 Certain chemical entities, compositions, and methods KIF5B, KIF2C, PLK1 CSNK2A1 401/4885NFKB1 3201/4885GLA 2181/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.